カテゴリー： Market Monitor Global, 世界, 医療/バイオ

胃がん治療の世界市場見通し2023年-2029年

◆英語タイトル：Gastric Cancer Therapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5578）

◆商品コード：MMG23JU5578
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gastric Cancer Therapy Market 調査レポートは次の情報を含め、グローバルにおけるの胃がん治療市場規模と予測を収録しています。・世界の胃がん治療市場：売上、2018年-2023年、2024年-2029年
・世界の胃がん治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の胃がん治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療用医薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

胃がん治療のグローバル主要企業は、Novartis AG、 Glaxo SmithKline Plc、 Roche Holding Limited、 AptarGroup Incorporated、 Squibb Company、 Boston Scientific Corporation、 Pfizer.、 Agilent Technologies, Inc.、 Illumina, Inc.、 Thermo Fisher Scientific, Inc.、 General Electric Company、 BD、 Abbott、 QIAGEN、 Siemens Healthcare GmbH、 F. Hoffmann-La Roche Ltd.、 Koninklijke Philips N.V.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Merck KGaAなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、胃がん治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の胃がん治療市場：タイプ別、2018年-2023年、2024年-2029年
世界の胃がん治療市場：タイプ別市場シェア、2022年
・医療用医薬品、一般用医薬品

世界の胃がん治療市場：用途別、2018年-2023年、2024年-2029年
世界の胃がん治療市場：用途別市場シェア、2022年
・オンライン販売、オフライン販売

世界の胃がん治療市場：地域・国別、2018年-2023年、2024年-2029年
世界の胃がん治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における胃がん治療のグローバル売上、2018年-2023年
・主要企業における胃がん治療のグローバル売上シェア、2022年
・主要企業における胃がん治療のグローバル販売量、2018年-2023年
・主要企業における胃がん治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis AG、 Glaxo SmithKline Plc、 Roche Holding Limited、 AptarGroup Incorporated、 Squibb Company、 Boston Scientific Corporation、 Pfizer.、 Agilent Technologies, Inc.、 Illumina, Inc.、 Thermo Fisher Scientific, Inc.、 General Electric Company、 BD、 Abbott、 QIAGEN、 Siemens Healthcare GmbH、 F. Hoffmann-La Roche Ltd.、 Koninklijke Philips N.V.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Merck KGaA

*************************************************************

・調査・分析レポートの概要
胃がん治療市場の定義
市場セグメント
世界の胃がん治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の胃がん治療市場規模
世界の胃がん治療市場規模：2022年 VS 2029年
世界の胃がん治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの胃がん治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の胃がん治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医療用医薬品、一般用医薬品
胃がん治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：オンライン販売、オフライン販売
胃がん治療の用途別グローバル売上・予測

・地域別市場分析
地域別胃がん治療市場規模 2022年と2029年
地域別胃がん治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis AG、 Glaxo SmithKline Plc、 Roche Holding Limited、 AptarGroup Incorporated、 Squibb Company、 Boston Scientific Corporation、 Pfizer.、 Agilent Technologies, Inc.、 Illumina, Inc.、 Thermo Fisher Scientific, Inc.、 General Electric Company、 BD、 Abbott、 QIAGEN、 Siemens Healthcare GmbH、 F. Hoffmann-La Roche Ltd.、 Koninklijke Philips N.V.、 Eli Lilly and Company、 F. Hoffmann-La Roche Ltd.、 Merck KGaA
...

Gastric Cancer Therapy is caused by uncontrolled abnormal cell proliferation that has the ability to spread and invade other sections of the body. Changes in the gene cause a single cell or a few cells to expand and replicate, which is when cancer begins. This could lead to the growth of a tumor, which is an abnormal mass of tissue. The creation of cancer cells in the stomach lining is known as Gastric Cancer Therapy or stomach cancer. Diet and stomach disorders are both risk factors for Gastric Cancer Therapy. Stomach pain, poor appetite, weight loss, indigestions, nausea, vomiting with or without blood are some of the symptoms of Gastric Cancer Therapy.
This report aims to provide a comprehensive presentation of the global market for Gastric Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Cancer Therapy. This report contains market size and forecasts of Gastric Cancer Therapy in global, including the following market information:
Global Gastric Cancer Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastric Cancer Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Gastric Cancer Therapy companies in 2022 (%)
The global Gastric Cancer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prescription Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gastric Cancer Therapy include Novartis AG, Glaxo SmithKline Plc, Roche Holding Limited, AptarGroup Incorporated, Squibb Company, Boston Scientific Corporation, Pfizer., Agilent Technologies, Inc. and Illumina, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastric Cancer Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastric Cancer Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Cancer Therapy Market Segment Percentages, by Type, 2022 (%)
Prescription Drugs
Non-Prescription Drugs
Global Gastric Cancer Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Cancer Therapy Market Segment Percentages, by Application, 2022 (%)
Online Sales
Offline Sales
Global Gastric Cancer Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Gastric Cancer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastric Cancer Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastric Cancer Therapy revenues share in global market, 2022 (%)
Key companies Gastric Cancer Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Gastric Cancer Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Glaxo SmithKline Plc
Roche Holding Limited
AptarGroup Incorporated
Squibb Company
Boston Scientific Corporation
Pfizer.
Agilent Technologies, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
General Electric Company
BD
Abbott
QIAGEN
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd.
Koninklijke Philips N.V.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Merck KGaA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastric Cancer Therapy, market overview.
Chapter 2: Global Gastric Cancer Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Gastric Cancer Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastric Cancer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastric Cancer Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gastric Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastric Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastric Cancer Therapy Overall Market Size
2.1 Global Gastric Cancer Therapy Market Size: 2022 VS 2029
2.2 Global Gastric Cancer Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gastric Cancer Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Gastric Cancer Therapy Players in Global Market
3.2 Top Global Gastric Cancer Therapy Companies Ranked by Revenue
3.3 Global Gastric Cancer Therapy Revenue by Companies
3.4 Global Gastric Cancer Therapy Sales by Companies
3.5 Global Gastric Cancer Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastric Cancer Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastric Cancer Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastric Cancer Therapy Players in Global Market
3.8.1 List of Global Tier 1 Gastric Cancer Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastric Cancer Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gastric Cancer Therapy Market Size Markets, 2022 & 2029
4.1.2 Prescription Drugs
4.1.3 Non-Prescription Drugs
4.2 By Type – Global Gastric Cancer Therapy Revenue & Forecasts
4.2.1 By Type – Global Gastric Cancer Therapy Revenue, 2018-2023
4.2.2 By Type – Global Gastric Cancer Therapy Revenue, 2024-2029
4.2.3 By Type – Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
4.3 By Type – Global Gastric Cancer Therapy Sales & Forecasts
4.3.1 By Type – Global Gastric Cancer Therapy Sales, 2018-2023
4.3.2 By Type – Global Gastric Cancer Therapy Sales, 2024-2029
4.3.3 By Type – Global Gastric Cancer Therapy Sales Market Share, 2018-2029
4.4 By Type – Global Gastric Cancer Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gastric Cancer Therapy Market Size, 2022 & 2029
5.1.2 Online Sales
5.1.3 Offline Sales
5.2 By Application – Global Gastric Cancer Therapy Revenue & Forecasts
5.2.1 By Application – Global Gastric Cancer Therapy Revenue, 2018-2023
5.2.2 By Application – Global Gastric Cancer Therapy Revenue, 2024-2029
5.2.3 By Application – Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
5.3 By Application – Global Gastric Cancer Therapy Sales & Forecasts
5.3.1 By Application – Global Gastric Cancer Therapy Sales, 2018-2023
5.3.2 By Application – Global Gastric Cancer Therapy Sales, 2024-2029
5.3.3 By Application – Global Gastric Cancer Therapy Sales Market Share, 2018-2029
5.4 By Application – Global Gastric Cancer Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gastric Cancer Therapy Market Size, 2022 & 2029
6.2 By Region – Global Gastric Cancer Therapy Revenue & Forecasts
6.2.1 By Region – Global Gastric Cancer Therapy Revenue, 2018-2023
6.2.2 By Region – Global Gastric Cancer Therapy Revenue, 2024-2029
6.2.3 By Region – Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
6.3 By Region – Global Gastric Cancer Therapy Sales & Forecasts
6.3.1 By Region – Global Gastric Cancer Therapy Sales, 2018-2023
6.3.2 By Region – Global Gastric Cancer Therapy Sales, 2024-2029
6.3.3 By Region – Global Gastric Cancer Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gastric Cancer Therapy Revenue, 2018-2029
6.4.2 By Country – North America Gastric Cancer Therapy Sales, 2018-2029
6.4.3 US Gastric Cancer Therapy Market Size, 2018-2029
6.4.4 Canada Gastric Cancer Therapy Market Size, 2018-2029
6.4.5 Mexico Gastric Cancer Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gastric Cancer Therapy Revenue, 2018-2029
6.5.2 By Country – Europe Gastric Cancer Therapy Sales, 2018-2029
6.5.3 Germany Gastric Cancer Therapy Market Size, 2018-2029
6.5.4 France Gastric Cancer Therapy Market Size, 2018-2029
6.5.5 U.K. Gastric Cancer Therapy Market Size, 2018-2029
6.5.6 Italy Gastric Cancer Therapy Market Size, 2018-2029
6.5.7 Russia Gastric Cancer Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Gastric Cancer Therapy Market Size, 2018-2029
6.5.9 Benelux Gastric Cancer Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gastric Cancer Therapy Revenue, 2018-2029
6.6.2 By Region – Asia Gastric Cancer Therapy Sales, 2018-2029
6.6.3 China Gastric Cancer Therapy Market Size, 2018-2029
6.6.4 Japan Gastric Cancer Therapy Market Size, 2018-2029
6.6.5 South Korea Gastric Cancer Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Gastric Cancer Therapy Market Size, 2018-2029
6.6.7 India Gastric Cancer Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gastric Cancer Therapy Revenue, 2018-2029
6.7.2 By Country – South America Gastric Cancer Therapy Sales, 2018-2029
6.7.3 Brazil Gastric Cancer Therapy Market Size, 2018-2029
6.7.4 Argentina Gastric Cancer Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gastric Cancer Therapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gastric Cancer Therapy Sales, 2018-2029
6.8.3 Turkey Gastric Cancer Therapy Market Size, 2018-2029
6.8.4 Israel Gastric Cancer Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Gastric Cancer Therapy Market Size, 2018-2029
6.8.6 UAE Gastric Cancer Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Gastric Cancer Therapy Major Product Offerings
7.1.4 Novartis AG Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Glaxo SmithKline Plc
7.2.1 Glaxo SmithKline Plc Company Summary
7.2.2 Glaxo SmithKline Plc Business Overview
7.2.3 Glaxo SmithKline Plc Gastric Cancer Therapy Major Product Offerings
7.2.4 Glaxo SmithKline Plc Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Glaxo SmithKline Plc Key News & Latest Developments
7.3 Roche Holding Limited
7.3.1 Roche Holding Limited Company Summary
7.3.2 Roche Holding Limited Business Overview
7.3.3 Roche Holding Limited Gastric Cancer Therapy Major Product Offerings
7.3.4 Roche Holding Limited Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Roche Holding Limited Key News & Latest Developments
7.4 AptarGroup Incorporated
7.4.1 AptarGroup Incorporated Company Summary
7.4.2 AptarGroup Incorporated Business Overview
7.4.3 AptarGroup Incorporated Gastric Cancer Therapy Major Product Offerings
7.4.4 AptarGroup Incorporated Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.4.5 AptarGroup Incorporated Key News & Latest Developments
7.5 Squibb Company
7.5.1 Squibb Company Company Summary
7.5.2 Squibb Company Business Overview
7.5.3 Squibb Company Gastric Cancer Therapy Major Product Offerings
7.5.4 Squibb Company Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Squibb Company Key News & Latest Developments
7.6 Boston Scientific Corporation
7.6.1 Boston Scientific Corporation Company Summary
7.6.2 Boston Scientific Corporation Business Overview
7.6.3 Boston Scientific Corporation Gastric Cancer Therapy Major Product Offerings
7.6.4 Boston Scientific Corporation Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Boston Scientific Corporation Key News & Latest Developments
7.7 Pfizer.
7.7.1 Pfizer. Company Summary
7.7.2 Pfizer. Business Overview
7.7.3 Pfizer. Gastric Cancer Therapy Major Product Offerings
7.7.4 Pfizer. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer. Key News & Latest Developments
7.8 Agilent Technologies, Inc.
7.8.1 Agilent Technologies, Inc. Company Summary
7.8.2 Agilent Technologies, Inc. Business Overview
7.8.3 Agilent Technologies, Inc. Gastric Cancer Therapy Major Product Offerings
7.8.4 Agilent Technologies, Inc. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Agilent Technologies, Inc. Key News & Latest Developments
7.9 Illumina, Inc.
7.9.1 Illumina, Inc. Company Summary
7.9.2 Illumina, Inc. Business Overview
7.9.3 Illumina, Inc. Gastric Cancer Therapy Major Product Offerings
7.9.4 Illumina, Inc. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Illumina, Inc. Key News & Latest Developments
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Thermo Fisher Scientific, Inc. Company Summary
7.10.2 Thermo Fisher Scientific, Inc. Business Overview
7.10.3 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Major Product Offerings
7.10.4 Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.11 General Electric Company
7.11.1 General Electric Company Company Summary
7.11.2 General Electric Company Gastric Cancer Therapy Business Overview
7.11.3 General Electric Company Gastric Cancer Therapy Major Product Offerings
7.11.4 General Electric Company Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.11.5 General Electric Company Key News & Latest Developments
7.12 BD
7.12.1 BD Company Summary
7.12.2 BD Gastric Cancer Therapy Business Overview
7.12.3 BD Gastric Cancer Therapy Major Product Offerings
7.12.4 BD Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.12.5 BD Key News & Latest Developments
7.13 Abbott
7.13.1 Abbott Company Summary
7.13.2 Abbott Gastric Cancer Therapy Business Overview
7.13.3 Abbott Gastric Cancer Therapy Major Product Offerings
7.13.4 Abbott Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Abbott Key News & Latest Developments
7.14 QIAGEN
7.14.1 QIAGEN Company Summary
7.14.2 QIAGEN Business Overview
7.14.3 QIAGEN Gastric Cancer Therapy Major Product Offerings
7.14.4 QIAGEN Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.14.5 QIAGEN Key News & Latest Developments
7.15 Siemens Healthcare GmbH
7.15.1 Siemens Healthcare GmbH Company Summary
7.15.2 Siemens Healthcare GmbH Business Overview
7.15.3 Siemens Healthcare GmbH Gastric Cancer Therapy Major Product Offerings
7.15.4 Siemens Healthcare GmbH Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Siemens Healthcare GmbH Key News & Latest Developments
7.16 F. Hoffmann-La Roche Ltd.
7.16.1 F. Hoffmann-La Roche Ltd. Company Summary
7.16.2 F. Hoffmann-La Roche Ltd. Business Overview
7.16.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Major Product Offerings
7.16.4 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.16.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.17 Koninklijke Philips N.V.
7.17.1 Koninklijke Philips N.V. Company Summary
7.17.2 Koninklijke Philips N.V. Business Overview
7.17.3 Koninklijke Philips N.V. Gastric Cancer Therapy Major Product Offerings
7.17.4 Koninklijke Philips N.V. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.17.5 Koninklijke Philips N.V. Key News & Latest Developments
7.18 Eli Lilly and Company
7.18.1 Eli Lilly and Company Company Summary
7.18.2 Eli Lilly and Company Business Overview
7.18.3 Eli Lilly and Company Gastric Cancer Therapy Major Product Offerings
7.18.4 Eli Lilly and Company Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.18.5 Eli Lilly and Company Key News & Latest Developments
7.19 F. Hoffmann-La Roche Ltd.
7.19.1 F. Hoffmann-La Roche Ltd. Company Summary
7.19.2 F. Hoffmann-La Roche Ltd. Business Overview
7.19.3 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Major Product Offerings
7.19.4 F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.19.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.20 Merck KGaA
7.20.1 Merck KGaA Company Summary
7.20.2 Merck KGaA Business Overview
7.20.3 Merck KGaA Gastric Cancer Therapy Major Product Offerings
7.20.4 Merck KGaA Gastric Cancer Therapy Sales and Revenue in Global (2018-2023)
7.20.5 Merck KGaA Key News & Latest Developments
8 Global Gastric Cancer Therapy Production Capacity, Analysis
8.1 Global Gastric Cancer Therapy Production Capacity, 2018-2029
8.2 Gastric Cancer Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastric Cancer Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastric Cancer Therapy Supply Chain Analysis
10.1 Gastric Cancer Therapy Industry Value Chain
10.2 Gastric Cancer Therapy Upstream Market
10.3 Gastric Cancer Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastric Cancer Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gastric Cancer Therapy in Global Market
Table 2. Top Gastric Cancer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastric Cancer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastric Cancer Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Gastric Cancer Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Gastric Cancer Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastric Cancer Therapy Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Gastric Cancer Therapy Product Type
Table 9. List of Global Tier 1 Gastric Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastric Cancer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gastric Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastric Cancer Therapy Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gastric Cancer Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Gastric Cancer Therapy Sales (K Units), 2024-2029
Table 16. By Application – Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gastric Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastric Cancer Therapy Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gastric Cancer Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Gastric Cancer Therapy Sales (K Units), 2024-2029
Table 21. By Region – Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gastric Cancer Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastric Cancer Therapy Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gastric Cancer Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Gastric Cancer Therapy Sales (K Units), 2024-2029
Table 26. By Country - North America Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastric Cancer Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gastric Cancer Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Gastric Cancer Therapy Sales, (K Units), 2024-2029
Table 30. By Country - Europe Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastric Cancer Therapy Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gastric Cancer Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Gastric Cancer Therapy Sales, (K Units), 2024-2029
Table 34. By Region - Asia Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastric Cancer Therapy Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gastric Cancer Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Gastric Cancer Therapy Sales, (K Units), 2024-2029
Table 38. By Country - South America Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastric Cancer Therapy Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gastric Cancer Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Gastric Cancer Therapy Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastric Cancer Therapy Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gastric Cancer Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Gastric Cancer Therapy Sales, (K Units), 2024-2029
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Gastric Cancer Therapy Product Offerings
Table 48. Novartis AG Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Glaxo SmithKline Plc Company Summary
Table 51. Glaxo SmithKline Plc Gastric Cancer Therapy Product Offerings
Table 52. Glaxo SmithKline Plc Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Glaxo SmithKline Plc Key News & Latest Developments
Table 54. Roche Holding Limited Company Summary
Table 55. Roche Holding Limited Gastric Cancer Therapy Product Offerings
Table 56. Roche Holding Limited Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Roche Holding Limited Key News & Latest Developments
Table 58. AptarGroup Incorporated Company Summary
Table 59. AptarGroup Incorporated Gastric Cancer Therapy Product Offerings
Table 60. AptarGroup Incorporated Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. AptarGroup Incorporated Key News & Latest Developments
Table 62. Squibb Company Company Summary
Table 63. Squibb Company Gastric Cancer Therapy Product Offerings
Table 64. Squibb Company Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Squibb Company Key News & Latest Developments
Table 66. Boston Scientific Corporation Company Summary
Table 67. Boston Scientific Corporation Gastric Cancer Therapy Product Offerings
Table 68. Boston Scientific Corporation Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Boston Scientific Corporation Key News & Latest Developments
Table 70. Pfizer. Company Summary
Table 71. Pfizer. Gastric Cancer Therapy Product Offerings
Table 72. Pfizer. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Pfizer. Key News & Latest Developments
Table 74. Agilent Technologies, Inc. Company Summary
Table 75. Agilent Technologies, Inc. Gastric Cancer Therapy Product Offerings
Table 76. Agilent Technologies, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Agilent Technologies, Inc. Key News & Latest Developments
Table 78. Illumina, Inc. Company Summary
Table 79. Illumina, Inc. Gastric Cancer Therapy Product Offerings
Table 80. Illumina, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Illumina, Inc. Key News & Latest Developments
Table 82. Thermo Fisher Scientific, Inc. Company Summary
Table 83. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Product Offerings
Table 84. Thermo Fisher Scientific, Inc. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 86. General Electric Company Company Summary
Table 87. General Electric Company Gastric Cancer Therapy Product Offerings
Table 88. General Electric Company Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. General Electric Company Key News & Latest Developments
Table 90. BD Company Summary
Table 91. BD Gastric Cancer Therapy Product Offerings
Table 92. BD Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. BD Key News & Latest Developments
Table 94. Abbott Company Summary
Table 95. Abbott Gastric Cancer Therapy Product Offerings
Table 96. Abbott Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Abbott Key News & Latest Developments
Table 98. QIAGEN Company Summary
Table 99. QIAGEN Gastric Cancer Therapy Product Offerings
Table 100. QIAGEN Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. QIAGEN Key News & Latest Developments
Table 102. Siemens Healthcare GmbH Company Summary
Table 103. Siemens Healthcare GmbH Gastric Cancer Therapy Product Offerings
Table 104. Siemens Healthcare GmbH Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Siemens Healthcare GmbH Key News & Latest Developments
Table 106. F. Hoffmann-La Roche Ltd. Company Summary
Table 107. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product Offerings
Table 108. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 110. Koninklijke Philips N.V. Company Summary
Table 111. Koninklijke Philips N.V. Gastric Cancer Therapy Product Offerings
Table 112. Koninklijke Philips N.V. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Koninklijke Philips N.V. Key News & Latest Developments
Table 114. Eli Lilly and Company Company Summary
Table 115. Eli Lilly and Company Gastric Cancer Therapy Product Offerings
Table 116. Eli Lilly and Company Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Eli Lilly and Company Key News & Latest Developments
Table 118. F. Hoffmann-La Roche Ltd. Company Summary
Table 119. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Product Offerings
Table 120. F. Hoffmann-La Roche Ltd. Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 122. Merck KGaA Company Summary
Table 123. Merck KGaA Gastric Cancer Therapy Product Offerings
Table 124. Merck KGaA Gastric Cancer Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Merck KGaA Key News & Latest Developments
Table 126. Gastric Cancer Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Gastric Cancer Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Gastric Cancer Therapy Production by Region, 2018-2023 (K Units)
Table 129. Global Gastric Cancer Therapy Production by Region, 2024-2029 (K Units)
Table 130. Gastric Cancer Therapy Market Opportunities & Trends in Global Market
Table 131. Gastric Cancer Therapy Market Drivers in Global Market
Table 132. Gastric Cancer Therapy Market Restraints in Global Market
Table 133. Gastric Cancer Therapy Raw Materials
Table 134. Gastric Cancer Therapy Raw Materials Suppliers in Global Market
Table 135. Typical Gastric Cancer Therapy Downstream
Table 136. Gastric Cancer Therapy Downstream Clients in Global Market
Table 137. Gastric Cancer Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastric Cancer Therapy Segment by Type in 2022
Figure 2. Gastric Cancer Therapy Segment by Application in 2022
Figure 3. Global Gastric Cancer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastric Cancer Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gastric Cancer Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. Gastric Cancer Therapy Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gastric Cancer Therapy Revenue in 2022
Figure 9. By Type - Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 12. By Type - Global Gastric Cancer Therapy Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 16. By Application - Global Gastric Cancer Therapy Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Gastric Cancer Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gastric Cancer Therapy Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 21. By Country - North America Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 23. US Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 28. Germany Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. France Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 37. China Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. India Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 44. Brazil Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gastric Cancer Therapy Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gastric Cancer Therapy Sales Market Share, 2018-2029
Figure 48. Turkey Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gastric Cancer Therapy Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gastric Cancer Therapy Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Gastric Cancer Therapy by Region, 2022 VS 2029
Figure 54. Gastric Cancer Therapy Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 胃がん治療の世界市場見通し2023年-2029年(Gastric Cancer Therapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

胃がん治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp